Shares of AngioDynamics ANGO jumped over 7% after the company reported upbeat Q3 results.
Quarterly Results
Earnings per share fell 94.74% year over year to $0.01, which beat the estimate of ($0.03).
Revenue of $69,780,000 lower by 19.18% from the same period last year, which beat the estimate of $68,550,000.
Looking Ahead
AngioDynamics hasn't issued any earnings guidance for the time being.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Apr 07, 2020
Time: 10:03 PM ET
Webcast URL: https://edge.media-server.com/mmc/p/cbupojap
Price Action
Company's 52-week high was at $23.61
Company's 52-week low was at $7.48
Price action over last quarter: down 28.94%
Company Description
AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.